XC219
XC219 (compound 43) is a covalent cyclin-dependent kinase (CDK) inhibitor that targets the active site lysine residue. This small molecule is applied in antifungal research, supporting in vitro studies to investigate CDK function in fungal cell cycle progression and viability.
Product Specifications
Field of Research
Cell Biology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1347698-01 0.02 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details MBS1347698-02 0.1 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details MBS1347698-03 0.02 mg (Yeast)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details MBS1347698-04 0.1 mg (Yeast)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details MBS1347698-05 0.02 mg (Baculovirus)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details MBS1347698-06 1 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv. viciae Urease subunit gamma (ureA)
Sign In for Pricing
View Details